Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PHIO PHARMACEUTICALS CORP.

(PHIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Phio Pharmaceuticals : HC Wainwright Adjusts Phio Pharmaceuticals' Price Target to $6 From $4, Keeps Buy Rating

06/14/2021 | 07:14am EDT


ę MT Newswires 2021
All news about PHIO PHARMACEUTICALS CORP.
09/16US Stocks Mostly Lower Thursday After Surprise Retail Sales Gain, Rise in Jobless Claim..
MT
09/16US Stocks End Mostly Lower as Investors Weigh Surprise Retail Sales Gain Against Rising..
MT
09/16Health Care Stocks Largely Sitting Out Markets Recovery This Afternoon
MT
09/16Health Care Stocks Muted in Premarket Thursday
MT
09/16PHIO PHARMACEUTICALS : Presents Data at ESMO 2021 Demonstrating Persistent Anti-Tumor Immu..
PR
09/16Phio Pharmaceuticals Presents Data at ESMO 2021 Demonstrating Persistent Anti-Tumor Imm..
CI
09/10PHIO PHARMACEUTICALS : HCW 23rd Annual Global Investment Conference Presentation
PU
09/06PHIO PHARMACEUTICALS : to Participate in the H.C. Wainwright 23rd Annual Global Investment..
AQ
09/03PHIO PHARMACEUTICALS : to Participate in the H.C. Wainwright 23rd Annual Global Investment..
PR
08/31PHIO PHARMACEUTICALS : Announces Upcoming Data Presentation at the ESMO Virtual Congress 2..
PR
More news
Analyst Recommendations on PHIO PHARMACEUTICALS CORP.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -14,1 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,95x
Yield 2021 -
Capitalization 29,1 M 29,1 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 0,58x
Nbr of Employees 10
Free-Float 99,7%
Chart PHIO PHARMACEUTICALS CORP.
Duration : Period :
Phio Pharmaceuticals Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHIO PHARMACEUTICALS CORP.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 2,15 $
Average target price 6,00 $
Spread / Average Target 179%
EPS Revisions
Managers and Directors
Gerrit Dispersyn President, Chief Executive Officer & Director
Caitlin Kontulis Secretary, VP-Finance & Administration
Robert J. Bitterman Chairman
Simon Fricker Vice President-Research
James Cardia Vice President-Business Operations
Sector and Competitors
1st jan.Capi. (M$)
PHIO PHARMACEUTICALS CORP.-20.07%29
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353